In a major expansion of the NVIDIA Clara™ healthcare platform, NVIDIA today announced breakthrough performance, key partnerships and new capabilities to help the medical community better track, test and treat COVID-19.
“The COVID-19 pandemic has supercharged the collaboration of technology, research and the healthcare industry to develop new computing solutions that accelerate the understanding of the spread, scale and severity of this disease,” said Kimberly Powell, vice president of Healthcare at NVIDIA. “Never before has there been such a critical need to apply the best AI technology and accelerated computing to every facet of healthcare, and its effects will be felt widely beyond this pandemic and across healthcare going forward.”
Genomics & Transcriptomics Pipelines at the Speed of Light
Running on just-announced NVIDIA A100 GPUs, NVIDIA Clara Parabricks achieved a record for DNA sequencing analysis of the whole genome — slashing analysis time to just under 20 minutes. NVIDIA also introduced GPU-accelerated RNA-sequencing pipelines that return results in less than 2 hours, giving researchers critical insights into patient susceptibility to disease, its progression, and response to treatment.
“Time is critical in the work we do. NVIDIA Clara Parabricks is being leveraged by researchers in the Center for Rare Childhood Disorders to help determine the most effective therapy for each patient and achieve our goal of delivering same-day results,” said Glen Otero, vice president of Scientific Computing at Translational Genomics Research Institute.
Source – Globe Newswire